<sc>d</sc>-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).
Simona DinicolaVittorio UnferChristophe O SoulageMaria Isidora Margarita Yap-GarciaArturo BevilacquaSalvatore BenvengaDaniele BarbaroArtur WdowiakMaurizio NordioDidier DewaillyMarialuisa AppetecchiaCesare AragonaMaria Salomè Bezerra EspinolaMariano BizzarriPietro CavalliAnnamaria ColaoRosario D'AnnaMónica Hebe Vazquez-LevinImelda Hernàndez MarinZdravko KamenovAntonio Simone LaganàGiovanni MonastraMario Montanino OlivaAli Cenk ÖzayBasilio PintaudiGiuseppina PorcaroOlga PustotinaLali PkhaladzeNikos PrapasScott RoseffSaghar SalehpourAnnarita StringaroMarat TugushevVirginia UnferIvana VucenikFabio FacchinettiPublished in: Gynecologic and obstetric investigation (2024)
<sc>d</sc>-Chiro-inositol mode of action has been studied in detail in recent years, resulting in a clear differentiation between <sc>d</sc>-chiro-inositol and its isomer myo-inositol. The insulin-sensitizing activities of <sc>d</sc>-chiro-inositol are well understood; however, its potential applications in other fields, in particular obesity and hyperestrogenic/hypoandrogenic disorders in men and women, represent promising avenues of research that require further clinical study.